Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Erythema
ADR ID BADD_A01535
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.03      Epidermal and dermal conditions
23.03.06      Erythemas
23.03.06.001      Erythema
Description Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes. [MeSH]
MedDRA Code 10015150
MeSH ID D004890
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Erythema | Erythema auricular | Erythema circumocular-blepharal | Erythema diffuse | Erythema facial | Erythema NOS | Erythema oedematous | Erythematous conditions | Face red | Localized erythema | Lower legs erythematous | Other specified erythematous condition | Other specified erythematous conditions | Red face | Red neck | Redness | Redness facial | Redness of external ear | Redness of face | Redness of legs | Skin erythema | Skin hyperaemia | Skin hyperemia | Skin red | Unspecified erythematous condition | Erythema periorbital | Redness in breast | Erythema ear | Erythema edematous | Infiltrative erythema | Localised erythema | Periungual erythema | Erythemas
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00271Bicalutamide--
BADD_D00274Bimatoprost0.027547%
BADD_D00277Bisoprolol0.009392%
BADD_D00280Bleomycin--
BADD_D00281Bleomycin sulfate--
BADD_D00282Blinatumomab--
BADD_D00283Boceprevir--
BADD_D00284Bortezomib--
BADD_D00285Bosentan--
BADD_D00286Bosutinib--
BADD_D00290Botulinum toxin type a--
BADD_D00293Brexpiprazole--
BADD_D00294Brimonidine0.026969%
BADD_D00295Brimonidine tartrate--
BADD_D00296Brinzolamide0.005359%
BADD_D00306Budesonide0.001422%
BADD_D00308Bupivacaine0.002759%
BADD_D00309Bupivacaine hydrochloride--
BADD_D00310Buprenorphine--
BADD_D00312Bupropion--
BADD_D00316Buspirone--
BADD_D00317Buspirone hydrochloride--
BADD_D00318Busulfan--
BADD_D00321Butenafine--
BADD_D00322Butenafine hydrochloride--
BADD_D00324Butorphanol--
BADD_D00326Butylscopolamine bromide--
BADD_D00328Cabazitaxel--
BADD_D00330Cabozantinib0.007992%
BADD_D00331Cabozantinib s-malate--
The 4th Page    First    Pre   4 5 6 7 8    Next   Last    Total 30 Pages